Research Paper Volume 15, Issue 12 pp 5650—5661
Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma
Figure 4. Landscape of immune cell infiltration in high- and low-risk lung adenocarcinoma (LUAD) patients. (A) Relative proportion of immune cell infiltration in high- and low-risk LUAD patients. (B) Correlation matrix of all 29 immune cell proportions. (C) Violin plots illustrating immune cells at significant proportions between high-risk and low-risk patients.